Skip to main content

Pain, Post-operative

8
Pipeline Programs
2
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
5
0
3
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Biocorp
BiocorpFrance - Issoire
6 programs
3
3
N1539Phase 31 trial
N1539Phase 31 trial
N1539Phase 31 trial
Intranasal DexmedetomidinePhase 21 trial
Intranasal DexmedetomidinePhase 21 trial
+1 more programs
Active Trials
NCT02284243Completed168Est. Jun 2015
NCT02169336Terminated95Est. Oct 2014
NCT02540265Completed59Est. Nov 2015
+3 more trials
Lotus Pharmaceuticals
Lotus PharmaceuticalsTaiwan - Taipei
2 programs
2
Intranasal DexmedetomidinePhase 2
Intranasal DexmedetomidinePhase 2

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BiocorpN1539
BiocorpN1539
BiocorpN1539
BiocorpN1539
BiocorpIntranasal Dexmedetomidine
BiocorpIntranasal Dexmedetomidine

Clinical Trials (6)

Total enrollment: 1,464 patients across 6 trials

NCT02720692BiocorpN1539

Evaluation of N1539 Following Major Surgery

Start: Mar 2016Est. completion: May 2017722 patients
Phase 3Completed
NCT02678286BiocorpN1539

Evaluation of N1539 Following Abdominoplasty Surgery

Start: Jan 2016Est. completion: Nov 2016219 patients
Phase 3Completed
NCT02675907BiocorpN1539

Evaluation of N1539 Following Bunionectomy Surgery

Start: Jan 2016Est. completion: Jul 2016201 patients
Phase 3Completed
NCT02540265BiocorpN1539

Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery

Start: Aug 2015Est. completion: Nov 201559 patients
Phase 2Completed
NCT02284243BiocorpIntranasal Dexmedetomidine

Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery

Start: Oct 2014Est. completion: Jun 2015168 patients
Phase 2Completed
NCT02169336BiocorpIntranasal Dexmedetomidine

Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy

Start: Jun 2014Est. completion: Oct 201495 patients
Phase 2Terminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.